Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Jun 30, 2025 | (Q2)Mar 31, 2025 | (Q1)Dec 31, 2024 | (FY)Sep 30, 2024 | (Q4)Sep 30, 2024 | (Q3)Jun 30, 2024 | (Q2)Mar 31, 2024 | (Q1)Dec 31, 2023 | (FY)Sep 30, 2023 | (Q4)Sep 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 23.41%-243.54K | 26.60%-196.62K | -146.21%-364.49K | 58.09%-1.11M | 76.82%-375.85K | -438.11%-317.96K | 10.18%-267.88K | 82.00%-148.04K | -154.15%-2.65M | -4,501.69%-1.62M |
| Net income from continuing operations | -31.11%-497.34K | 43.82%-320.18K | -21.54%-562.43K | 57.59%-1.98M | 81.58%-563.72K | 21.33%-379.32K | 5.76%-569.94K | 9.57%-462.76K | 3.06%-4.66M | -17,289.74%-3.06M |
| Operating gains losses | ---- | ---- | ---- | 258.86%194.15K | --0 | --0 | ---- | ---- | 195.61%54.1K | --1 |
| Remuneration paid in stock | 163.21%164.25K | 17.93%114.8K | 67.86%233.1K | -63.21%329.01K | -83.41%30.4K | -69.81%62.4K | -58.28%97.34K | -48.77%138.87K | -78.03%894.25K | -40.34%183.21K |
| Other non cashItems | --0 | --0 | 85.93%-31.8K | 23.15%-296.66K | 54.40%-70.63K | --0 | --0 | 2.20%-226.02K | 0.87%-386.01K | 42.73%-154.9K |
| Change In working capital | 8,769.60%89.56K | -17.10%8.77K | -100.84%-3.37K | -55.84%639.53K | -83.82%228.11K | -100.28%-1.03K | -85.57%10.58K | 199.33%401.87K | 2,134.67%1.45M | 8,116.86%1.41M |
| -Change in receivables | -104.65%-2.38K | -36.04%84.46K | -116.33%-47.7K | -75.69%468.91K | -96.45%45.94K | -100.24%-1.16K | 13.20%132.05K | 901.80%292.09K | 1,649.33%1.93M | 332.54%1.29M |
| -Change in prepaid assets | -88.11%3.3K | -69.93%6.26K | -171.42%-49.96K | 260.88%158.96K | 602.05%40.41K | 61.22%27.77K | -23.03%20.83K | 151.80%69.95K | -452.31%-98.81K | -117.25%-8.05K |
| -Change in payables and accrued expense | 420.69%88.63K | 42.41%-81.95K | 136.70%94.29K | 103.06%11.66K | 14.57%141.77K | 79.70%-27.64K | -102.00%-142.3K | 113.34%39.84K | -336.63%-381.52K | 134.04%123.74K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 23.41%-243.54K | 26.60%-196.62K | -146.21%-364.49K | 58.09%-1.11M | 76.82%-375.85K | -438.11%-317.96K | 10.18%-267.88K | 82.00%-148.04K | -154.15%-2.65M | -4,501.69%-1.62M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | -5.13%185.85K | 0 | 0 | 102.56%195.9K | 167.08%1.57M | ||||
| Net PPE purchase and sale | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Net investment purchase and sale | --0 | ---- | ---- | -5.13%185.85K | --0 | --0 | ---- | ---- | 48.75%195.9K | --0 |
| Net other investing changes | ---- | ---- | ---- | ---- | ---- | -264.96%-173.96K | ---- | ---- | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | ---- | ---- | -5.13%185.85K | --0 | --0 | ---- | ---- | 102.56%195.9K | 167.08%1.57M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 0 | 1,349.80%499.92K | 32.31%425.64K | -29.40%787.84K | 87.5K | 418.65K | -114.12%-40K | -61.37%321.69K | -78.65%1.12M | 0 |
| Net issuance payments of debt | --0 | ---- | ---- | ---40K | --0 | --0 | ---- | ---- | --0 | --0 |
| Net common stock issuance | --0 | --515K | 29.21%452.5K | -5.03%800.2K | --0 | --450K | --0 | -58.44%350.2K | -85.22%842.62K | --0 |
| Proceeds from stock option exercised by employees | ---- | ---- | ---- | --0 | --0 | --0 | ---- | ---- | 2,733.33%283.33K | --0 |
| Net other financing activities | --0 | ---15.08K | 5.78%-26.86K | 377.62%27.64K | --87.5K | ---31.35K | --0 | -186.37%-28.51K | 97.29%-9.96K | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | --0 | 1,349.80%499.92K | 32.31%425.64K | -29.40%787.84K | --87.5K | --418.65K | -114.12%-40K | -61.37%321.69K | -78.65%1.12M | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | 93.38%366.14K | -79.82%62.84K | -98.77%1.69K | -90.66%137.71K | 53.43%290.03K | 32.72%189.34K | -69.61%311.36K | -90.66%137.71K | -70.14%1.47M | -94.79%189.03K |
| Current changes in cash | -341.85%-243.54K | 348.56%303.31K | -64.79%61.15K | 89.82%-136.02K | -461.89%-288.35K | 117.15%100.7K | 86.16%-122.03K | 138.66%173.65K | 61.40%-1.34M | 97.61%-51.32K |
| End cash Position | -57.73%122.61K | 93.38%366.14K | -79.82%62.84K | -98.77%1.69K | -98.77%1.69K | 53.43%290.03K | 32.72%189.34K | -69.61%311.36K | -90.66%137.71K | -90.66%137.71K |
| Free cash from | 23.41%-243.54K | 26.60%-196.62K | -146.21%-364.49K | 58.09%-1.11M | 76.82%-375.85K | -438.11%-317.96K | 10.18%-267.88K | 82.00%-148.04K | -154.15%-2.65M | -4,501.69%-1.62M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.